Capital

Vital signs

Why it's on the table

On the table, Capital (Cp) is seat 56 of 58, in the Human Elements family. It is a stable element — the category has settled, choosing is cheap, and switching is rare. Pick a holder and move on; this is not where your decision budget should go. It is optional: plenty of companies run without it — until a specific trigger (scale, regulation, cost, or customers) makes it essential for them. The price of entry is zero, which makes trying it a decision that needs no meeting.

Capital: the top 5 — v2026.Q3

Edition v2026.Q3 · ranking, pricing and status verified 2026-08-06.

1. 1Customers (revenue as capital)your users — via pre-sales, deposits, design-partner contracts, annual-prepay

   0% dilution · 0% APR · cost is time and the discount you give early customers (annual prepay typically 10–20% off)

   Best for Software with a working wedge and a buyer who feels the pain now — the default route for AI-led startups small enough that agents replace headcount.

   The 2026 math changed: capital concentrated so hard that non-frontier startups can't count on it — OpenAI and Anthropic alone took $217B, or 43% of all H1 2026 startup funding (Crunchbase). Global Q2 seed was $12B, but it barbelled: $2.8B went into seed rounds of $100M+ while $5B went into rounds of $10M and under. Revenue is also the key to every other door here — Founderpath's floor is $10K MRR, Lighter's is $200K ARR, venture debt's is roughly $1M ARR plus a Series A.

   Watch Slowest route by far, and it caps what you can attempt — you cannot pre-sell your way into a frontier training run or a two-year research bet. Customer money comes with real strings: annual prepay discounts cut effective price, and design-partner contracts can quietly turn your roadmap into their roadmap. Concentration risk is the failure mode nobody prices.

   OpenAI + Anthropic captured $217B — 43% of all H1 2026 startup funding; AI took >70% of Q2 global startup capital, up from ~50% a year earlier (Crunchbase, Jul 2026) [src] · Q2 2026 global seed = $12B, barbelled: $2.8B in seed rounds of $100M+, $5B in rounds of $10M and under (Crunchbase, Jul 2026) [src] · Revenue is the gate to non-dilutive capital: Founderpath floor $10K MRR (~$120K ARR); Lighter Capital floor $200K ARR / $15K MRR plus 5 paying customers (Aug 2026) [src]
   Site →Docs →

2. 2AcceleratorsY Combinator · Neo · a16z Speedrun · HF0 · South Park Commons · EF · Antler

   YC $500K = $125K for 7% post-money + $375K uncapped MFN · Neo $750K uncapped SAFE, up to 5% in next round (0.75% at a $100M round) · a16z Speedrun up to $1M + $8M+ credits · HF0 $1M uncapped for 5% or $500K + 3% · SPC $400K for 7% + $600K guaranteed next round · EF US $250K for 8% · Antler US $250K for 9.09%

   Best for A working wedge that needs a network, a deadline, and a brand stamp more than it needs the money — and founders who can absorb 5–9% dilution for it.

   YC's terms have not moved since January 11, 2022 — $125K for a fixed 7% plus $375K uncapped MFN — and its scarcity is the product: roughly 1.5–2% acceptance from 12,000–15,000 applications per batch. But 2026 broke the price cartel. Neo launched $750K on an uncapped SAFE in February 2026, capping participation at 5% of the next round — meaning a founder who raises at $100M gives up 0.75%, roughly a tenth of YC's take. HF0 stays deliberately tiny at 10 teams per batch and its S25 cohort averaged $82M post-demo-day valuations with a top team at $20M annualized revenue.

   Watch The 7% is real money — at a $100M next round that is $7M for a 12-week program you may not need. YC's own edge is now heavily brand and batch network rather than terms, and Neo/Speedrun/HF0 all beat it on dilution. Selectivity cuts both ways: a rejection consumes months of founder attention, and the batch calendar imposes a demo-day narrative that can push companies to raise before they should. Antler's US terms ($250K/9.09%) are the most expensive on the list and date from an October 2023 announcement — confirm they still stand before applying.

   YC standard deal unchanged since Jan 11, 2022: $125K for fixed 7% post-money + $375K uncapped MFN SAFE, with pro rata rights (verified on ycombinator.com/deal, Aug 2026) [src] · Neo: $750K uncapped SAFE, participation capped at 5% of next round — 5% at a $15M round, 0.75% at $100M (announced Feb 19, 2026) [src] · a16z Speedrun: up to $1M + $8M+ in credits; $180M+ deployed across 150+ startups since 2023; SR007 runs Jul 27 – Oct 11, 2026 [src]
   Site →Docs →

3. 3Pre-seed & seed rounds (angels + AI funds)seed funds, solo GPs, angel syndicates — priced rounds and post-money SAFEs

   ~20% founder dilution at seed (Carta, 2026) · median seed post-money $24M, ~$16M pre, $3.1M median round · AI seed valuations run ~40%+ above non-AI peers

   Best for Teams that need $2–5M at once — GPU spend, a founding engineering team, or an 18–24 month runway to $1M ARR — and are willing to sell a fifth of the company for it.

   This is still the largest single route by dollars and the only one that funds a company that isn't yet default-alive. The instrument standardized around YC's post-money SAFE (uncapped, capped, or discount variants — plus Canada, Cayman and Singapore versions), which makes dilution computable on day one. The AI premium is real and quantified: Carta puts seed post-money median at $24M in 2026, with AI companies raising roughly 1.3x larger rounds at valuations ~40%+ above non-AI peers, and AI foundational-model Series A medians near $300M against ~$55M for non-AI.

   Watch The premium is not evenly distributed — it accrues to the frontier and to credentialed teams. Application-layer AI startups increasingly get priced as ordinary software, and the $5B of Q2 seed that went into rounds of $10M-and-under is where most founders actually live. ~20% dilution at seed compounds: a seed plus a Series A puts most founders under 50% before the company is proven. And post-money SAFEs stack — three uncapped notes and a priced round can dilute far past what any single term sheet implied.

   2026 seed medians: $24M post-money, ~$16M pre, $3.1M round size, ~20% founder dilution (Carta data, 2026) [src] · AI premium: ~1.3x larger seed rounds and ~40%+ higher valuations vs non-AI; AI foundational-model Series A medians near $300M vs ~$55M non-AI (2026) [src] · Carta 'State of Pre-Seed: Q1 2026' — pre-seed funding matched recent quarters, indicating market stabilization; dataset spans 50,000+ startups [src]
   Site →Docs →

4. 4Revenue-based financing & venture debtFounderpath · Lighter Capital · Stripe Capital · Hercules / TriplePoint (venture debt)

   Founderpath: 7% flat discount on revenue financing (a $200K advance repays $214K), term loans from 15%, MCA from 5% of monthly revenue, no closing or prepayment fees · Lighter Capital: up to $10M, rates undisclosed · Venture debt: 8–15% APR (SOFR ~4.5% + 6–9% spread) plus 1–5% warrant coverage

   Best for Predictable recurring revenue you want to convert into cash without selling equity — funding a sales hire, bridging a seasonal gap, or extending runway between priced rounds.

   The only route that buys you money without buying your company. Founderpath has deployed $271M across 742 companies since 2021 at an average deal near $600–750K, funds in 24 hours to 2 weeks off a data connection, and takes no equity, board seat, warrants, or personal guarantee. Lighter Capital goes to $10M with a $200K ARR floor across US, Canada and Australia. Venture debt scales further — typically 25–35% of your last equity round, over 1–4 years with 6–12 months interest-only — but only after a Series A.

   Watch The category shrank hard. Pipe wound down its direct SaaS revenue-trading marketplace back in early 2024 and is now embedded Capital-as-a-Service delivered only through partners like UberEats, GoCardless, Boulevard and Housecall Pro; it cut roughly 50% of staff in November 2025 and changed CEO in December. Capchase left too — its $200M+ raise in May 2026 funds B2B buy-now-pay-later vendor financing, not founder RBF. What remains is smaller and stricter. And a flat 7% discount is not 7% APR: repaid over 12 months it is roughly a low-teens effective annual rate, and worse on short terms. Venture debt adds warrants (so it is not truly non-dilutive) plus covenants that can trigger exactly when you're weakest.

   Founderpath: $271M deployed across 742 companies since 2021; 7% flat discount, 12–36 month terms, funded in 24h–2 weeks; $10K MRR floor (Aug 2026) [src] · Pipe wound down direct SaaS RBF in early 2024, pivoted to embedded Capital-as-a-Service; ~50% workforce cut Nov 2025, CEO change Dec 2025 [src] · Venture debt 2026: 8–15% APR (SOFR ~4.5% + 6–9% spread), 1–5% warrant coverage, 25–35% of last equity round, needs Series A + ~$1M ARR [src]
   Site →Docs →

5. 5Equity crowdfunding (Reg CF)Wefunder · Republic · StartEngine

   Wefunder 7.9% of a successful Reg CF raise + $1,000/yr admin, no upfront fee · Republic 7% cash + 2% securities = 9% · Reg CF cap $5M per 12 months · plus real legal, audit and marketing costs on top

   Best for Consumer products and community-native companies whose users would genuinely want to own a piece — and founders who want capital without a lead investor's governance.

   It is the only route on this list where your customers become your cap table, and it is the only one with no gatekeeper: no partner meeting, no acceptance rate, no Series A prerequisite. Wefunder is the scale player at $826M in cumulative volume across ~3.29M investors, with roughly 75% of campaigns hitting their minimum and a typical raise near $350K. The $5M annual Reg CF ceiling is enough to be a real pre-seed or bridge.

   Watch Ranked last for good reason. The 7.9–9% platform fee is a genuine cost of capital, and it is only 30–40% of the true expense once legal, audited financials and campaign marketing are counted. Volumes are tiny and consolidating — Republic did $15.6M in US Reg CF in 2024, about 6% of Wefunder's $99.4M, and has since pivoted toward accredited-only deal rooms, SPVs and tokenization after buying INX for $60M in April 2025. A messy cap table of hundreds of small holders can complicate later priced rounds, and B2B AI startups rarely have the crowd that makes this work at all.

   Wefunder: $826M cumulative volume, ~3.29M investors; 7.9% success fee on Reg CF + $1,000/yr admin, no upfront fee [src] · Republic charges 7% cash + 2% securities (9%); did $15.6M US Reg CF in 2024 vs Wefunder's $99.4M; acquired INX for $60M (Apr 2025) and pivoted toward accredited/tokenized products [src] · Wefunder median raise ~$350K, ~75% of campaigns hit minimum; Reg CF ceiling $5M per 12 months; platform fees are only 30–40% of true fundraising cost [src]
   Site →Docs →

Capital: the top 9 compared

Edition v2026.Q3 · ranking, pricing and status verified 2026-08-06.

How to choose your capital

If you can reach $10K MRR before you need money

Do that first, then take non-dilutive capital. $10K MRR is Founderpath's floor and $200K ARR is Lighter's; both take 0% equity, no board seat, no warrants. Every dollar of revenue makes every other route on this list cheaper.

If you want an accelerator and you're optimizing for dilution rather than brand

Apply to Neo before YC. Neo's $750K uncapped SAFE caps participation at 5% of the next round — 0.75% if you raise at $100M — against YC's fixed 7%. Take YC anyway if the batch network and the stamp are the actual product you're buying.

If you need $3M+ at once for compute or a founding team, and you are not default-alive

Raise a priced seed and budget ~20% dilution (Carta 2026 median: $24M post, $3.1M round). Do not stack three uncapped SAFEs hoping to avoid the conversation — post-money notes compound and the reckoning arrives at the priced round.

If you are an application-layer AI startup and everyone tells you funding is easy right now

Assume it isn't for you. AI took >70% of Q2 2026 capital but OpenAI and Anthropic alone took 43% of the H1 total; the $5B of Q2 seed that landed in rounds of $10M-and-under is the real market. Plan to be default-alive.

If someone pitches you revenue-based financing at 'only 7%'

Convert it to an annual rate before signing. A 7% flat discount repaid over 12 months is roughly a low-teens effective APR and materially worse on shorter terms — still often cheaper than 20% equity, but not the number on the tin.

If you're a B2B AI startup considering equity crowdfunding

Skip it. Reg CF works when you already have a crowd; 7.9–9% in platform fees plus legal and audit against a ~$350K median raise is a bad trade without one. Revisit only if your users would genuinely want to own the thing.

Capital: the whole field

25 more tools tracked in this category, including 4 dead, renamed, or sunsetting — a reference that hides the graveyard isn't one. Verified 2026-08-06.

Capital: the category in numbers

Edition v2026.Q3 · ranking, pricing and status verified 2026-08-06.

• Global startup funding hit a record $510B in H1 2026 — more than all of 2025's $440B — with AI taking over 70% of Q2 global capital, up from ~50% a year earlier [src]
• Concentration is the whole story: OpenAI and Anthropic together captured $217B — 43% of all H1 2026 startup funding; Anthropic alone raised $65B in Q2 [src]
• Seed barbelled in Q2 2026: of $12B in global seed, $2.8B went to seed rounds of $100M+ and $5B to rounds of $10M and under — the middle thinned out [src]
• 2026 seed medians (Carta): $24M post-money, ~$16M pre, $3.1M round, ~20% founder dilution — with AI companies raising ~1.3x larger rounds at ~40%+ higher valuations than non-AI peers [src]
• Accelerator terms competition arrived in 2026: Neo launched $750K on an uncapped SAFE capped at 5% of the next round (Feb 19, 2026), undercutting YC's fixed 7% by roughly 10x at a $100M valuation [src]
• Founder-facing revenue-based financing consolidated: Pipe exited the direct SaaS marketplace (early 2024, ~50% layoffs Nov 2025) and Capchase pivoted entirely to B2B vendor financing (raising $200M+ in May 2026), leaving Founderpath and Lighter Capital as the main direct options [src]
• Exit markets reopened — Q2 2026 saw 32 companies go public above $1B and 24 acquisitions above $1B totaling $113B, the highest quarterly acquisition value on record, including SpaceX's $1.77T IPO and its $60B purchase of Anysphere [src]

Capital: method & sources

Verification grades. [V] verified on the provider's own page: YC's $500K deal terms (ycombinator.com/deal), YC's SAFE document set, EF's US terms ($250K/8%, $10K fellowship grant), SPC's F26 fellowship ($400K/7% + $600K), a16z Speedrun's 'up to $1M + $8M+ credits' and SR007 dates, Neo's $750K/5%-of-next-round and cohort structure (neo.substack.com), Founderpath's rates and $271M/742-company track record, Lighter Capital's $200K ARR floor and $10M ceiling, Pipe's current partner-only Capital product, Capchase's vendor-financing pivot. [P] partial — aggregator or press only, re-check before acting: HF0's terms ($1M uncapped for 5% or $500K + 3%) appear only on third-party aggregators; HF0's own site publishes batch outcomes but not terms. Antler's US terms ($250K for 9.09% at $2.75M post, $2,500 relocation grant) trace to an October 2023 announcement and were not reconfirmed for 2026 — the Feb 2026 Nordic relaunch (€500K continuous residency) suggests terms are in flux regionally. a16z Speedrun's equity percentage is not published; the '$500K for 10% plus $500K if the next round closes within 18 months' structure comes from TechCrunch's Feb 2026 Neo piece, not from a16z. YC's acceptance rate (~1.5–2%, 12–15k applications, 200–250 admits) and the '3–5x conversion for applicants with revenue' claim are aggregator estimates — YC does not publish these. Techstars' status as 'fading' reflects widely reported program closures since 2024 and is a judgment call, not a vendor statement. Conflicts resolved. Wefunder's Reg CF success fee is reported as both 7.5% and 7.9%; we use 7.9% because CrowdSpace's platform profile itemizes it alongside the $1,000/yr admin fee and the specific investor payment fees, which reads as a current fee schedule rather than a rounded summary. Founderpath's minimum is stated as '$500K last-year revenue' on its homepage and '$10K MRR (~$120K ARR)' on its revenue-based-financing page; we cite the lower $10K MRR figure as the product floor and treat $500K as the underwriting comfort zone — both are Founderpath's own numbers, so confirm which applies to you. Founderpath's average deal size is given as ~$600K on the RBF page and ~$750K as the '2026 average' on the homepage; both are cited. Note that Founderpath is also the publisher of the Pipe and Capchase competitor analyses cited here — the underlying facts (Pipe's partner-only product, Capchase's $200M vendor-financing raise) are independently corroborated by pipe.com, capchase.com and the May 2026 funding coverage, but the framing is a competitor's. Cost-of-capital caveat. A '7% flat discount' is not a 7% APR. Repaid over 12 months, a $200K advance costing $14K is roughly a low-teens effective annual rate; over 6 months it is materially worse. Founderpath is transparent that the cost is fixed and known on day one, which is a genuine advantage over accruing debt — but compare instruments on an annualized basis before choosing. Similarly, venture debt's 1–5% warrant coverage means it is not truly non-dilutive. Scope. This element covers routes to funding. Mentors and advisor equity (0.1–0.5%, vested) live in Mn · Mentors & Advisors — accelerator alumni networks are a Cp benefit but the mentoring practice belongs there. Founder communities such as Indie Hackers and MicroConf belong to Co · Community. Cap-table and equity administration tooling belongs to Eq. Fractional CFOs who run a raise belong to Fx. Legal work on financing documents belongs to La. Compute credits are listed here because accelerators now bundle them as a material part of the offer, but infrastructure procurement itself is not this element's job. Editorial charter. Ranking is by cost of capital, control retained, and realistic accessibility to a non-frontier AI-led startup in Aug 2026 — not by dollar volume, which would put priced rounds first. Customers rank first because the H1 2026 concentration data shows most founders cannot rely on the funding boom that headlines describe, and because revenue is a prerequisite for three of the other four routes. No affiliate consideration; all picks are editorial. Ranking criteria: verified commercial traction, independent satisfaction surveys, agent benchmarks, and founder-fit (price floor, lock-in, surfaces). Editorial, never paid — the charter. Machine-readable twin: cp.json.

Our take

The 2026 twist: default-alive is achievable solo, so capital is a choice, not a requirement. Choose deliberately.

Combines with